G935-1929 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

G935-1929 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one
G935-1929 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G935-1929
1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G935-1929

Molecular Formula

C25H33N5O5S (C25 H33 N5 O5 S)

Compound Name

1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

IUPAC name

1-(23-dihydro-1H-indol-1-yl)-2-(35-dimethyl-4-{[4-(morpholine-4-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

SMILES

Cc(n(CC(N(CC1)c2c1cccc2)=O)nc1C)c1S(N(CC1)CCC1C(N1CCOCC1)=O)(=O)=O

InChI

InChI=1S/C25H33N5O5S/c1-18-24(19(2)30(26-18)17-23(31)29-12-9-20-5-3-4-6-22(20)29)36(33,34)28-10-7-21(8-11-28)25(32)27-13-15-35-16-14-27/h3-6,21H,7-17H2,1-2H3

InChI Key

ZMVBSDWCQLXWEW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15075974

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

515.63

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.373

Distribution Coefficient, logD

0.373

Water Solubility, LogSw

-2.10

Polar Surface Area

86.211

Acid Dissociation Constant (pKa)

23.38

Base Dissociation Constant (pKb)

0.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.00

G935-1929 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G935-1929 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G935-1929?
Check Price and Availability of G935-1929, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G935-1929 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G935-1929
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G935-1929
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G935-1929 available by request